| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930564 | Cytotherapy | 2014 | 12 Pages |
Abstract
Clinical-scale isolation of “minimally manipulated” CMV-specific donor CTLs through the use of MHC class I streptamers is feasible and yields functional CTLs at clinically relevant dosages.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Marcus Odendahl, G. Ulrich Grigoleit, Halvard Bönig, Michael Neuenhahn, Julia Albrecht, Florian Anderl, Lothar Germeroth, Marc Schmitz, Martin Bornhäuser, Hermann Einsele, Erhard Seifried, Dirk H. Busch, Torsten Tonn,